XBiotech (XBIT) Announces EMA Negative 'Trend' Vote Related to MAA for Candidate Antibody for Treatment of Colorectal Cancer
Tweet Send to a Friend
XBiotech Inc. (NASDAQ: XBIT) announced today that the European Medicines Agency (EMA) rendered a negative “trend” vote after meeting with ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
